Acute renal failure early after heart transplantation: Risk factors and clinical consequences

Clinical Transplantation

Volumn 24, Issue 6, 2010, Pages

  Gude, Einar ^a   Andreassen, Arne K ^a   Arora, Satish ^a   Gullestad, Lars ^a,b   Grov, Ingelin ^a   Hartmann, Anders ^a,b   Leivestad, Torbjørn ^a   Fiane, Arnt E ^a,b   Geiran, Odd R ^a,b   Vardal, Mari ^a   Simonsen, Svein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute renal failure; Cyclosporine; Heart transplantation; Hemodialysis; Nephrotoxicity

Indexed keywords

CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; GRAFT REJECTION; HEART OUTPUT; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; FEMALE; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649810253     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01225.x     Document Type: Article

References (24)

1. Holzmann MJ, Hammar N, Ahnve S, Nordqvist T, Pehrsson K, Ivert T. Renal insufficiency and long-term mortality and incidence of myocardial infarction in patients undergoing coronary artery bypass grafting. Eur Heart J 2007: 28: 865.
2. Gruberg L, Mintz GS, Mehran R, Gangas G. The prognostic implication of further renal function detoriation within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000: 36: 1542.
3. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003: 349: 931.
4. Greenberg A, Egel JW, Thompson ME et al. Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. Am J Kidney Dis 1987: 9: 12.
5. Boyle JM, Moualla S, Arrigain S et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis 2006: 48: 787.
6. Odim J, Wheat J, Laks H et al. Peri-operative renal function and outcome after orthotopic heart transplantation. J Heart Lung Transplant 2006: 25: 162.
7. Stevens LM, El-Hamamsy I, Leblanc M et al. Continuous renal replacement therapy after heart transplantation. Can J Cardiol 2004: 20: 619.
8. Ostermann ME, Rogers CA, Saeed I, Nelson SR, Murday AJ. Pre-existing renal failure doubles 30-day mortality after heart transplantation. J Heart Lung Transplant 2004: 23: 1231.
9. Wyatt C, Arons R. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 2004: 78: 1351.
10. Mehra MR, Kobashigawa J, Starling R et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006: 25: 1024.
11. Williams EF, Lake CL. Cyclosporine A and cardiopulmonary bypass. Anesth Analg 1992: 75: 1072.
12. Mehta R, Kellum J, Shah S et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007: 11: R31.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999: 130: 461.
14. Canarovich M, Hirsh A, Alam A et al. The clinical impact of an early decline in kidney function in patients following heart transplantation. Am J Transplant 2009: 9: 348.
15. Arora S, Andreassen A, Simonsen S et al. Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy. Transplantation 2007: 84: 149.
16. Deuse T, Haddad F, Pham M et al. Twenty-year survivors of heart transplantation at Stanford University. Am J Transplant 2008: 8: 1769.
17. Caforio AL, Tona F, Piaserico S et al. C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl Int 2005: 18: 116.
18. Beauchesne PR, Chung NS, Wasan KM. Cyclosporine A: a review of current oral and intravenous delivery systems. Drug Dev Ind Pharm 2007: 33: 211.
19. Banner NR, David OJ, Leaver N et al. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Transpl Int 2002: 15: 649.
20. Valantine H. Neoral use in the cardiac transplant recipient. Transplant Proc 2000: 32: 27S.
21. Taylor DO, Stehlik J, Leah B et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant 2009: 28: 1007.
22. Rosenberg PB, Vriesendorp AE, Drazner MH et al. Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. J Heart Lung Transplant 2005: 24: 1327.
23. Delgado DH, Miriuka SG, Cusimano RJ, Feindel C, Rao V, Ross HJ. Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction. J Heart Lung Transplant 2005: 24: 166.
24. Meiser B, Reichart B, Adamidis I, Uberfuhr P, Kaczmarek I. First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation. Am J Transplant 2005: 5: 827.